Investors Capital Advisory Services’s Pfizer PFE Stock Holding History

Investors Capital Advisory Services’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$4.14M	Buy	124,073 +1,332	+1%	+$42.5K	0.79%	14
2016 Q1	$3.45M	Buy	122,741 +5,189	+4%	+$148K	0.69%	17
2015 Q4	$3.6M	Sell	117,552 -11,767	-9%	-$370K	0.7%	13
2015 Q3	$3.85M	Buy	129,319 +2,821	+2%	+$90.5K	0.77%	11
2015 Q2	$4.02M	Buy	126,498 +7,105	+6%	+$232K	0.74%	14
2015 Q1	$3.94M	Sell	119,393 -790	-0.7%	-$25.1K	0.73%	17
2014 Q4	$3.55M	Buy	120,183 +5,638	+5%	+$162K	0.68%	20
2014 Q3	$3.21M	Sell	114,545 -6,276	-5%	-$176K	0.63%	24
2014 Q2	$3.4M	Buy	120,821 +770	+0.6%	+$21.9K	0.55%	27
2014 Q1	$3.66M	Sell	120,051 -2,037	-2%	-$60.7K	0.79%	17
2013 Q4	$3.55M	Buy	122,088 +4,810	+4%	+$140K	0.83%	16
2013 Q3	$3.19M	Buy	117,278 +5,415	+5%	+$147K	0.83%	14
2013 Q2	$2.97M	Buy	+111,863	New	+$3.09M	0.91%	15

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Investors Capital Advisory Services's PFE Position: Q2 2016 in Review

Investors Capital Advisory Services increased its Pfizer (PFE) stake by 1.1% in Q2 2016, buying an estimated $42.5K and bringing the position to 124,073 shares worth $4.14M. The position accounts for 0.79% of the portfolio, ranked #14.

Investors Capital Advisory Services first reported a position in PFE in Q2 2013 and has held it in 13 quarters since. 1,991 funds tracked by Wall St. Rank hold PFE as of Q2 2016.

Investors Capital Advisory Services held 124,073 shares of Pfizer worth $4.14M as of Q2 2016.
Investors Capital Advisory Services bought 1,332 Pfizer shares in Q2 2016, an estimated $42.5K.
Pfizer made up 0.79% of Investors Capital Advisory Services's portfolio in Q2 2016, its #14 holding.
Investors Capital Advisory Services first reported a position in Pfizer in Q2 2013 and has held it in 13 quarters since.
1,991 funds tracked by Wall St. Rank held Pfizer as of Q2 2016.

Based on Investors Capital Advisory Services's 13F filing for Q2 2016, filed 2 Aug 2016.